Fallahi-Sichani is an assistant professor of biomedical engineering – a joint department of the schools of Engineering and Medicine – teaching two upper-level courses, “Systems Bioengineering” and “Bioreaction Kinetics (Biomedical and Pharmacological Perspectives).”
His research in systems pharmacology, funded by the National Cancer Institute, “dissects the complex responses of cells to therapeutic interventions, particularly those that lead to drug resistance of tumors to anti-cancer therapies in human patients,” he wrote in email. By understanding drug response mechanisms, he and his research team look for innovative strategies to induce selective killing in cancer cells while reducing the undesired adverse effects in healthy cells.
“I look forward to enjoying fruitful collaborations between my lab and other labs across diverse disciplines, including data science, engineering and cancer biology,” Fallahi-Sichani said.